These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 27283163
21. [Clinical pathological features of the 8p11 myeloproliferative syndrome]. Yan Z, Yang B, Wang QS, Wang LL, Han XP, Ren F, Yu L. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285 [Abstract] [Full Text] [Related]
24. Isodicentric 20q- in two cases of B-cell acute lymphocytic leukemia with the respective t(9;20)(p11;q11.2) and t(9;22)(q34;q11.2). Li T, Xue Y, Zhang J, Chen S, Pan J, Wu Y, Wang Y, Shen J. Cancer Genet Cytogenet; 2008 Feb; 181(1):55-9. PubMed ID: 18262055 [Abstract] [Full Text] [Related]
25. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature. Kim WS, Park SG, Park G, Jang SJ, Moon DS, Kang SH. Acta Haematol; 2015 Feb; 133(1):101-5. PubMed ID: 25227135 [Abstract] [Full Text] [Related]
28. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review. Konishi Y, Kondo T, Nakao K, Asagoe K, Otsuka Y, Nishikori M, Hishizawa M, Yamashita K, Takaori-Kondo A. Bone Marrow Transplant; 2019 Feb; 54(2):326-329. PubMed ID: 30087462 [No Abstract] [Full Text] [Related]
29. [Clinical and laboratory characteristics of two acute lymphoblastic leukemia patients with dicentric (9; 20) (p11 - 13; q11)]. Gong SL, Qiu HY, Li JY, Han FL, Song XM, Huang ZX, Wang JM. Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):306-9. PubMed ID: 16875578 [Abstract] [Full Text] [Related]
31. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement. Freyer CW, Hughes ME, Carulli A, Bagg A, Hexner E. Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350 [Abstract] [Full Text] [Related]
33. Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/BCR-FGFR1-rearranged myeloid/lymphoid neoplasm with RUNX1 mutation - diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib. Manur R, Sung PJ, Loren AW, Ritchie EK, Frank D, Bagg A, Geyer JT, Bogusz AM. Leuk Lymphoma; 2020 Feb; 61(2):450-454. PubMed ID: 31524018 [No Abstract] [Full Text] [Related]
34. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia. Marinelli LM, Romain JT, Ehman W, Ortega V, Velagaleti G, Gibbons TF, Nazario-Toole A, Holmes AR. Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761 [Abstract] [Full Text] [Related]
35. Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcript. Duployez N, Nibourel O, Ducourneau B, Grardel N, Boyer T, Bories C, Darre S, Coiteux V, Berthon C, Preudhomme C, Roche-Lestienne C. Eur J Haematol; 2016 Oct; 97(4):399-402. PubMed ID: 26935241 [Abstract] [Full Text] [Related]
38. A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome. Kjeldsen E. Exp Mol Pathol; 2015 Aug; 99(1):50-5. PubMed ID: 25962659 [Abstract] [Full Text] [Related]